This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Graybill, J. R. Articles by Larsen, R. A. Search for Related Content PubMed PubMed Citation Articles by Graybill, J. R. Articles by Larsen, R. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2003, p. 2373-2375, Vol. 47, No. 7
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.7.2373-2375.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Addition of Caspofungin to Fluconazole Does Not Improve Outcome in Murine Candidiasis

The University of Texas Health Science Center at San Antonio Department of Medicine, Division of Infectious Diseases, San Antonio, Texas 78229-3900,¹ Division of Infectious Diseases, Department of Medicine, University of Southern California, Los Angeles, California 90033²

Received 20 February 2003/ Returned for modification 13 March 2003/ Accepted 10 April 2003

Caspofungin is a potent antifungal inhibiting glucan synthesis in Candida species. However, caspofungin is not 100% curative in candidiasis. Therefore, we evaluated combinations of fluconazole with caspofungin for murine candidemia. We could not show any benefit of combined therapy over individual antifungal drugs.

This article has been cited by other articles:

• Ibrahim, A. S., Bowman, J. C., Avanessian, V., Brown, K., Spellberg, B., Edwards, J. E. Jr., Douglas, C. M. (2005). Caspofungin Inhibits Rhizopus oryzae 1,3-{beta}-D-Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated Zygomycosis. Antimicrob. Agents Chemother. 49: 721-727 [Abstract] [Full Text]  
• Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., Ghannoum, M. A. (2005). Combination Treatment of Invasive Fungal Infections. Clin. Microbiol. Rev. 18: 163-194 [Abstract] [Full Text]  
• MacCallum, D. M., Odds, F. C. (2004). Need for Early Antifungal Treatment Confirmed in Experimental Disseminated Candida albicans Infection. Antimicrob. Agents Chemother. 48: 4911-4914 [Abstract] [Full Text]  
• Cuenca-Estrella, M. (2004). Combinations of antifungal agents in therapy-what value are they?. J Antimicrob Chemother 54: 854-869 [Abstract] [Full Text]  
• Barchiesi, F., Spreghini, E., Baldassarri, I., Marigliano, A., Arzeni, D., Giannini, D., Scalise, G. (2004). Sequential Therapy with Caspofungin and Fluconazole for Candida albicans Infection. Antimicrob. Agents Chemother. 48: 4056-4058 [Abstract] [Full Text]  
• Barchiesi, F., Spreghini, E., Maracci, M., Fothergill, A. W., Baldassarri, I., Rinaldi, M. G., Scalise, G. (2004). In Vitro Activities of Voriconazole in Combination with Three Other Antifungal Agents against Candida glabrata. Antimicrob. Agents Chemother. 48: 3317-3322 [Abstract] [Full Text]  
• Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., Rex, J. H. (2004). Combination Antifungal Therapy. Antimicrob. Agents Chemother. 48: 693-715 [Full Text]